CIK 0001034842 · Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943248524
- Phone
- 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-04 | RODRIGUEZ RAUL R CEO, President | Sale | −4,952 | $20.92 | $104K | 243,854 |
| 2025-02-04 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Sale | −1,448 | $20.92 | $30K | 40,169 |
| 2025-01-29 | Rojkjaer Lisa EVP, Chief Medical Officer | Grant or award | +19,717 | 19,717 | ||
| 2025-01-29 | Rojkjaer Lisa EVP, Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +14,788 | 14,788 | ||
| 2025-01-29 | RODRIGUEZ RAUL R CEO, President | Grant or award | +42,300 | 248,806 | ||
| 2025-01-29 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (Right to Buy) | +63,400 | 63,400 | ||
| 2025-01-29 | Schorno Dean L EVP & Chief Financial Officer | Grant or award | +19,717 | 61,005 | ||
| 2025-01-29 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +14,788 | 14,788 | ||
| 2025-01-29 | Santos David A EVP, Chief Commercial Officer | Grant or award | +19,717 | 55,625 | ||
| 2025-01-29 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +14,788 | 14,788 | ||
| 2025-01-29 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award | +19,717 | 41,617 | ||
| 2025-01-29 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award · Employee Stock Option (Right to Buy) | +14,788 | 14,788 | ||
| 2025-01-24 | RODRIGUEZ RAUL R CEO, President | Option exercise | +45,000 | $21.40 | $963K | 249,662 |
| 2025-01-24 | RODRIGUEZ RAUL R CEO, President | Shares withheld for taxes | −44,078 | $22.17 | $977K | 205,584 |
| 2025-01-24 | RODRIGUEZ RAUL R CEO, President | Option exercise | +45,000 | $21.40 | $963K | 250,584 |
| 2025-01-24 | RODRIGUEZ RAUL R CEO, President | Shares withheld for taxes | −44,078 | $22.17 | $977K | 206,506 |
| 2025-01-24 | RODRIGUEZ RAUL R CEO, President | Option exercise · Employee Stock Option (right to buy) | −45,000 | 0 | ||
| 2025-01-24 | RODRIGUEZ RAUL R CEO, President | Option exercise · Employee Stock Option (right to buy) | −45,000 | 0 | ||
| 2024-11-25 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2024-11-25 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 |
Page 6 of 9 · 176 trades